Skip to contentI
InspireMD, Inc.
I
NSPRInspireMD, Inc. Q3 2024 · 10-Q
Revenue$1.81M$1.81M+16.3% vs Q3 2023 Net Income-$7.89M-$7.89MN/M vs Q3 2023 EPS Diluted-$0.16-$0.16N/M vs Q3 2023 Gross Profit$414,000−5.5% Operating Income
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
InspireMD, Inc. · CIK 1433607 · Engraved from SEC EDGAR
Operating Cash Flowderived-$5,700,000N/M Free Cash Flowderived-$6,121,000N/M Margins · derivedGross margin22.9%−5.3 pt vs Q3 2023
Operating margin-467.5%−105.1 pt vs Q3 2023
Net margin-435.9%−103.1 pt vs Q3 2023
ended Sep 30, 2024 · filed Nov 12, 2024 · 43 d after period end